Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
From: Pharmacological Treatment of Parkinson DiseaseA Review JAMA. 2014;311(16):1670-1683. doi:10.1001/jama.2014.3654 Figure Legend: Schematic Illustration of Neurologic Pathways Affected in Parkinson Disease and Sites of Action of Medications for the Treatment of Motor SymptomsAvailable medications to treat the motor symptoms of Parkinson disease act on complex neurologic interactions in the striatum that affect motor activity. Dopaminergic afferents from the substantia nigra, glutamatergic afferents from the cerebral cortex and thalamus, and cholinergic striatal interneurons all converge to influence the activity of the main efferent neurons of the striatum, the medium spiny GABAergic neurons.Copyright Levodopa is transported from the peripheral circulation across the blood-brain © 2014 American Medical Date of and download: 5/12/2017 barrier is converted centrally to dopamine, replacing the neurotransmitter Association. All rights reserved.deficient in Parkinson disease. Outside the bloodbrain barrier, in the peripheral circulation, dopamine decarboxylase inhibitors (DDCIs) block the conversion of levodopa to From: Pharmacological Treatment of Parkinson DiseaseA Review JAMA. 2014;311(16):1670-1683. doi:10.1001/jama.2014.3654 Figure Legend: Algorithm for the Treatment of Parkinson Disease With Tremor-Dominant Motor SymptomsaAnticholinergic use is anecdotal and not supported by randomized clinical trials.bIf the patient experiences inadequate symptom control while on current therapy and there was more than 1 treatment option in the previous step, go back to previous step and try an alternate treatment option. If all options in the previous step fail to provide adequate symptom control, move to the next step in the algorithm. cSuboptimal benefit is defined as improvement in parkinsonian symptoms following initiation of therapy, the patient still experiences a bothersome or disabling Copyright © 2014 Americanbut Medical Date of download: 5/12/2017 degree of symptoms either continuously or intermittently. In these cases, increase the dose of current medication if the patient is not Association. All rights reserved. receiving a maximal dose or add another medication. If benefit is absent, stop the current medication and try another. dSurgery for From: Pharmacological Treatment of Parkinson DiseaseA Review JAMA. 2014;311(16):1670-1683. doi:10.1001/jama.2014.3654 Figure Legend: Algorithm for the Treatment of Parkinson Disease With Predominant Bradykinesia and Impaired Dexterity aSuboptimal benefit is defined as improvement in parkinsonian symptoms following initiation of therapy, but the patient still experiences a bothersome or disabling degree of symptoms either continuously or intermittently. In these cases, increase the dose of current medication if the patient is not receiving a maximal dose or add another medication. If benefit is absent, stop the current medication and try another.bIf the patient experiences inadequate symptom on current Copyrightcontrol © 2014 while American Medicaltherapy and there was more than 1 treatment Date of in download: 5/12/2017 option the previous step, go back to previous step and try an alternate treatment option. If all options in the previous step fail to Association. All rights reserved. provide adequate symptom control, move to the next step in the algorithm. From: Pharmacological Treatment of Parkinson DiseaseA Review JAMA. 2014;311(16):1670-1683. doi:10.1001/jama.2014.3654 Figure Legend: Algorithm for the Treatment of Parkinson Disease With Predominant Postural Instability and Gait Impairment aSuboptimal benefit is defined as improvement in parkinsonian symptoms following initiation of therapy, but the patient still experiences a bothersome or disabling degree of symptoms either continuously or intermittently. In these cases, increase the dose of current medication if the patient is not receiving a maximal dose or add another medication. If benefit is absent, stop the current medication and try another.bIf the patient experiences inadequate symptom on current Copyrightcontrol © 2014 while American Medicaltherapy and there was more than 1 treatment Date of in download: 5/12/2017 option the previous step, go back to previous step and try an alternate treatment option. If all options in the previous step fail to Association. All rights reserved. c provide adequate symptom control, move to the next step in the algorithm. Persistent ambulatory problems including freezing,